Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
In combination with tirzepatide
Maximize manufacturer savings programs and copay cards
What the SELECT Trial Mediation Analysis Revealed The most definitive clinical evidence that cardiovascular protection is not driven by weight loss comes from a prespecified analysis of the SELECT trial, which enrolled 17,604 patients with obesity and established cardiovascular disease but no diabetes
Compounded semaglutide and tirzepatide products are not the same as FDA-approved brand-name medications
US$ 25.67
US$ 24.21
US$ 21.26
